In this video, Dr. Patrick Nemechek discusses his general clinical approach to using rifaximin in adults as part of his broader framework for microbiome management and recovery from chronic neurological problems—especially autonomic-related symptoms. He focuses on practical questions patients and clinicians often have: what rifaximin is (in his description), what it is intended to do in his protocol, what patients typically feel when starting it, and how he decides when to stop or repeat a course.
He emphasizes that the way he uses rifaximin is not a one-size-fits-all plan. In his clinical approach, the timing and duration depend on how disrupted a patient’s life is by symptoms, whether they have intestinal symptoms (or not), and how quickly the initial symptom response appears.
How Dr. Nemechek describes rifaximin and why he uses it
Dr. Nemechek calls rifaximin a “very unique antibiotic” and frames its role narrowly: in his words, “the only thing it can do is help improve the balance of your bacteria.” In the video, he highlights several reasons he considers it distinct in clinical use:
- Biome impact (as he describes it): he states it is “the only known antibiotic that won’t damage your biome,” and that it helps improve bacterial balance consistently.
- Resistance (as he describes it): he states it is “the only known antibiotic where there is no long-term resistance,” meaning the medication “won’t quit working after a while.”
- Systemic absorption (as he describes it): he describes it as one of the very few drugs that does not get into the bloodstream, and therefore, in his explanation, it should not interact with other medicines and “can’t irritate your liver” because it cannot reach the liver through the bloodstream.
Within his adult recovery framework, he also states that adults “need fish oil and olive oil,” that most need a “VEO stimulator” to recover, and that in his clinical experience they “all need rifaximin to recover” from the neurological chronic neurological problems he is focused on—specifically autonomics—while also noting that it “helps with chronic depression” and “a whole lot of other things.”
Starting rifaximin in milder cases: a short course and reassessment
Dr. Nemechek explains that when symptoms are “fairly mild” in how much they disrupt a person’s life, and the patient has intestinal symptoms (he gives an example such as certain foods causing heartburn), he may start with a 10-day course. In the video, he describes this initial course as taken twice a day.
He pairs that with the other elements he mentions (fish oil, olive oil, and the VEO stimulator), but for rifaximin specifically his goal is to see how the patient responds and whether the improved bacterial balance “stays that way.” If it does, he explains that a patient might not need another round for “a few to several months.”
He also describes how patients may notice early changes, such as realizing within “a week or two” that their intestinal tract feels better. The key in his approach is that patients learn what signals a relapse for them personally.
What patients may feel when starting: “gurgly,” but not a “die-off” picture
A common worry with microbiome-directed treatments is whether someone will feel acutely worse. In the video, Dr. Nemechek says some patients report that the first day or two can feel “a little gurgly.” At the same time, he explicitly contrasts this with more severe reactions: he says patients are not describing vomiting, there is “no diarrhea,” and “no die off” type of response—“none of that.”
This is presented as his practical counseling point: what a mild early adjustment can feel like, and what he does not typically see patients report in his clinical use.
Recognizing relapse: the symptom “fingerprint” approach
Dr. Nemechek describes a pattern he uses to help patients know when rifaximin is helping and when it may be needed again. He explains that certain symptoms often improve within the first week on rifaximin, and he calls this the patient’s “SIBO fingerprint” (he pronounces it as “SEO fingerprint” in the audio, but the context is bacterial overgrowth/SIBO).
He notes that this fingerprint is “typically some intestinal stuff,” but in his clinical experience it can also include non-intestinal symptoms such as:
- lightheadedness improving a lot
- anxiety improving a lot
In his framework, after rifaximin is stopped, the patient watches for the return of the same fingerprint symptoms. When those symptoms come back, that is his signal to consider another short course.
Longer continuous courses in more severe neurological disruption (including long COVID patients)
Dr. Nemechek then describes a different situation: adults who are “severely affected neurologically.” He specifically mentions seeing this in “long hauler COVID patients.” In these cases, he describes that some patients may have no intestinal symptoms from SIBO—he estimates “25–30%” fall into that category. Without intestinal symptoms, he explains, it can be harder to “see the relapsing,” so he may keep them on rifaximin continuously for longer.
In the video, he describes putting these patients on rifaximin twice a day non-stop and notes that duration can vary: “4 months, 6, 8 months,” depending on how long it takes for the patient to recover function. He adds a commonsense clinical principle: “the worse you are the longer to recovery.”
When patients have improved significantly after several months of continuous use, he describes stopping rifaximin and then “coasting” while continuing other parts of the plan (he reiterates that patients remain on fish oil and olive oil, and may continue the VNS/VEO stimulator depending on recovery).
Stopping, coasting, and repeating: how he times future 10-day courses
After a longer continuous course, Dr. Nemechek describes a stop-and-observe phase. He asks patients to monitor for the return of their fingerprint symptoms. In his experience, those symptoms might come back in “a month,” but he says “typically it’s several months.”
When the fingerprint returns, he describes using a 10-day course again, and then observing what resolves. The cycle can repeat: he gives an example of symptoms returning again “6 months, 12 months,” followed by another 10-day course, and so on. In his framing, this is “how the whole thing starts and finishes” as patients and clinicians learn the individual pattern over time.
Important medical disclaimer
Want to Learn More About POTS and Autonomic Dysfunction?
Download Dr. Nemechek’s free POTS/PANS/PANDAS eBook for a deeper explanation of autonomic dysfunction, inflammation, and recovery.
This article summarizes statements from Dr. Nemechek’s video and is for education only. It is not medical advice and is not a substitute for individualized care. Antibiotics and neuromodulation devices should only be used under the guidance of a licensed clinician who can evaluate risks, benefits, and appropriateness for your specific situation and medications.
